• |
  • |
  • |
  • |
Donate

Project

PHARM - A Multi-Center, Double-Blind, Randomized, Parallel Group, Placebo-Controlled Study of Aripiprazole in the treatment of Autistic Disorder

Center:
Fiscal Year:
2008
Contact Information:
Project Description:
This is an industry sponsored, 8-week study in which 220 children with autistic disorder accompanied by tantrums, aggression, and/or self injury will be randomly assigned to aripiprazole or placebo.
Keyword(s):
Autism, Irritability, Agression, Clinical Trial
Core Function(s):
Performing Research or Evaluation
Area of Emphasis
Health-Related Activities
Target Audience:
Children/Adolescents with Disabilities/SHCN
Unserved or Under-served Populations:
Specific Groups
Primary Target Audience Geographic Descriptor:
State, National
Funding Source:
COVID-19 Related Data:
N/A